MSD Animal Health introduce exciting year-round flea and tick treatment for dogs in a single injection.

Bravecto® Injectable is an innovative year-round flea and tick treatment for dogs administered in a single injection. This latest addition to the Bravecto portfolio is reconstituted to provide an 150mg/ml multidose suspension of fluralaner. The product is intended for dogs from 6 months of age and provides 12-month duration of efficacy against key flea and tick species from the onset of efficacy.  For further details about this product click here

BRAVECTO® Injectable (BRAVECTO 150 mg/ml powder and solvent for suspension for injection for dogs) has a 12-month duration of efficacy against flea and tick species indicated on the SPC and contains fluralaner.  POM-V.  

Further information is available from the SPC, datasheet or package leaflet. Prescription decisions are for the person issuing the prescription alone. Advice should be sought from the medical prescriber. 

Use Medicines Responsibly. 

MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942. All trademarks are property of their respective owners. 

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. 

Come and visit us at London Vet Show 2024, stand L20!

Rachel Dickinson  

[email protected] 

It’s Time… to present the Bravecto Injectable European Field Trial

Save your seat